Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Equity Ratio (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Equity Ratio for 13 consecutive years, with 0.92 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 0.73% year-over-year to 0.92, compared with a TTM value of 0.92 through Dec 2025, down 0.73%, and an annual FY2025 reading of 0.92, down 0.73% over the prior year.
  • Equity Ratio was 0.92 for Q4 2025 at Agios Pharmaceuticals, down from 0.93 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.94 in Q1 2025 and bottomed at 0.85 in Q2 2024.
  • Average Equity Ratio over 5 years is 0.9, with a median of 0.9 recorded in 2022.
  • The sharpest move saw Equity Ratio skyrocketed 91.86% in 2021, then dropped 3.84% in 2024.
  • Year by year, Equity Ratio stood at 0.9 in 2021, then fell by 1.11% to 0.89 in 2022, then dropped by 2.61% to 0.87 in 2023, then grew by 7.06% to 0.93 in 2024, then fell by 0.73% to 0.92 in 2025.
  • Business Quant data shows Equity Ratio for AGIO at 0.92 in Q4 2025, 0.93 in Q3 2025, and 0.93 in Q2 2025.